These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3725283)

  • 1. Failure of allopurinol to provide clinically significant protection against the hematologic toxicity of a bolus 5-FU schedule.
    Garewal H; Ahmann FR
    Oncology; 1986; 43(4):216-8. PubMed ID: 3725283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose allopurinol modulation of 5-FU toxicity: phase I trial of an outpatient dose schedule.
    Campbell TN; Howell SB; Pfeifle C; House BA
    Cancer Treat Rep; 1982 Sep; 66(9):1723-7. PubMed ID: 7116349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of allopurinol on the toxicity of high-dose 5-fluorouracil administered by intermittent bolus injection.
    Howell SB; Pfeifle CE; Wung WE
    Cancer; 1983 Jan; 51(2):220-5. PubMed ID: 6336975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of the effect of 4-hydroxypyrazolopyrimidine (allopurinol) on the toxicity of a single bolus dose of 5-fluorouracil.
    Woolley PV; Ayoob MJ; Smith FP; Lokey JL; DeGreen P; Marantz A; Schein PS
    J Clin Oncol; 1985 Jan; 3(1):103-9. PubMed ID: 3965628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I and pharmacologic study of PN401 and fluorouracil in patients with advanced solid malignancies.
    Hidalgo M; Villalona-Calero MA; Eckhardt SG; Drengler RL; Rodriguez G; Hammond LA; Diab SG; Weiss G; Garner AM; Campbell E; Davidson K; Louie A; O'Neil JD; von Borstel R; Von Hoff DD; Rowinsky EK
    J Clin Oncol; 2000 Jan; 18(1):167-77. PubMed ID: 10623707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized phase I and II study of short-term infusion of high-dose fluorouracil with or without N-(phosphonacetyl)-L-aspartic acid in patients with advanced pancreatic and colorectal cancers.
    Ardalan B; Singh G; Silberman H
    J Clin Oncol; 1988 Jun; 6(6):1053-8. PubMed ID: 3373260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma.
    Petrelli N; Herrera L; Rustum Y; Burke P; Creaven P; Stulc J; Emrich LJ; Mittelman A
    J Clin Oncol; 1987 Oct; 5(10):1559-65. PubMed ID: 2443619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.
    Lokich JJ; Ahlgren JD; Gullo JJ; Philips JA; Fryer JG
    J Clin Oncol; 1989 Apr; 7(4):425-32. PubMed ID: 2926468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer.
    Chen LT; Liu TW; Wu CW; Chung TR; Shiah HS; Jan CM; Liu JM; Whang-Peng J; Chang JY
    Oncology; 2002; 63(3):239-47. PubMed ID: 12381903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of high-dose continuous infusion 5-fluorouracil with allopurinol modulation in colon cancer.
    Ahmann FR; Garewal H; Greenberg BR
    Oncology; 1986; 43(2):83-5. PubMed ID: 3951789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant administration of 4-hydroxypyrazolopyrimidine (allopurinol) and high-dose continuous infusion 5-fluorouracil.
    Tsavaris N; Karagiaouris P; Vonorta K; Bacogianis H; Milonakis N; Karvounis N; Kakoliris S; Zepou E; Karabelis A; Papazahariou M
    Oncology; 1990; 47(1):70-4. PubMed ID: 2300389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
    Forastiere AA; Natale RB; Takasugi BJ; Goren MP; Vogel WC; Kudla-Hatch V
    J Clin Oncol; 1987 Feb; 5(2):190-6. PubMed ID: 3543242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin plus 5-FU for the treatment of adenocarcinoma of the colon.
    Loehrer PJ; Einhorn LH; Williams SD; Hui SL; Estes NC; Pennington K
    Cancer Treat Rep; 1985 Dec; 69(12):1359-63. PubMed ID: 4075311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
    Yamada Y; Ohtsu A; Boku N; Miyata Y; Shimada Y; Doi T; Muro K; Muto M; Hamaguchi T; Mera K; Yano T; Tanigawara Y; Shirao K
    Jpn J Clin Oncol; 2006 Apr; 36(4):218-23. PubMed ID: 16684860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-FU and allopurinol: toxicity modulation and phase II results in colon cancer.
    Kroener JF; Saleh F; Howell SB
    Cancer Treat Rep; 1982 May; 66(5):1133-7. PubMed ID: 7083215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.
    Kreuser ED; Hilgenfeld RU; Matthias M; Hoksch B; Boewer C; Oldenkott B; Knauf WU; Boese-Landgraf J; Schalhorn A; Zeitz M
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):197-203. PubMed ID: 1557647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial of weekly intensive therapy with 5-fluorouracil on two different schedules combined with interferon alpha-2a and filgrastim in patients with advanced solid tumors: Eastern Cooperative Oncology Group Study P-Z991.
    Wadler S; Atkins M; Karp D; Neuberg D; Haynes H; Dutcher JP
    Cancer J Sci Am; 1998; 4(4):261-8. PubMed ID: 9689985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer.
    Caponigro F; Avallone A; McLeod H; Cartenì G; De Vita F; Casaretti R; Morsman J; Blackie R; Budillon A; De Lucia L; Gravina A; Catalano G; Comella P; Comella G
    Clin Cancer Res; 1999 Dec; 5(12):3948-55. PubMed ID: 10632324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.